James Mulay
Director at CG Oncology, Inc. (CGON)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $4.0M
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Jul 14SEC | CGONCG Oncology, Inc. | Sell Plan | 24,165 | $75.16 | $1.8M | -15.1% |
| Jun 16SEC | CGONCG Oncology, Inc. | Sell Plan | 654 | $60.12 | $39K | +6.2% |
| Jun 16SEC | CGONCG Oncology, Inc. | Sell Plan | 1,310 | $60.12 | $79K | +6.2% |
| Apr 20SEC | CGONCG Oncology, Inc. | Sell Plan | 15,600 | $73.01 | $1.1M | -12.6% |
| Mar 17SEC | CGONCG Oncology, Inc. | Sell Plan | 654 | $63.50 | $42K | +0.5% |
| Mar 17SEC | CGONCG Oncology, Inc. | Sell Plan | 1,310 | $63.50 | $83K | +0.5% |
| Jan 13SEC | CGONCG Oncology, Inc. | Sell Plan | 654 | $44.16 | $29K | +44.5% |
| Jan 13SEC | CGONCG Oncology, Inc. | Sell Plan | 10,491 | $52.99 | $556K | +20.4% |
| Oct 10SEC | CGONCG Oncology, Inc. | Sell Plan | 5,903 | $43.99 | $260K | +45.1% |
- Sell
Director James Mulay sold $1.8M of CGON at $75.16 — pre-scheduled 10b5-1 plan sale.
- Sell
Director James Mulay sold $39K of CGON at $60.12 — pre-scheduled 10b5-1 plan sale.
- Sell
Director James Mulay sold $79K of CGON at $60.12 — pre-scheduled 10b5-1 plan sale.
- Sell
Director James Mulay sold $1.1M of CGON at $73.01 — pre-scheduled 10b5-1 plan sale.
- Sell
Director James Mulay sold $42K of CGON at $63.50 — pre-scheduled 10b5-1 plan sale.
- Sell
Director James Mulay sold $83K of CGON at $63.50 — pre-scheduled 10b5-1 plan sale.